Oral Contraceptives Suppress Ovarian Hormone Production

Arnold M. Tóth I. Faredin I. (1980). Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author’s transl). Deutsche Zahn-, Mund-, und Kieferheilkunde mit Zentralblatt, 68, 713–718.

Balogh A. Ditroi F. Lampe L.G. (1981). LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception. Acta Universitatis Palackianae Olomucensis Facultatis Medicae, 101, 95–101.

Basu J. Mikhail M.S. Palan P.R. Thysen B. Bloch E. Romney S.L. (1992). Endogenous estradiol and progesterone concentrations in smokers on oral contraceptives. Gynecologic and Obstetric Investigation, 33, 224–227.

Chan M. Dowsett M. Folkerd E. Wareham N. Luben R. Welch A. . (2008). Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women. Menopause, 15, 332–339.

Drife J. (1996). The benefits and risks of oral contraceptives today (1st ed.). Pearl River, NY: Parthenon Publishing Group.

Fleischman D.S. Fessler D.M.T. (2010). Progestin effects on the psychology of disease avoidance: Support for the compensatory behavioral prophylaxis hypothesis. Manuscript in preparation.

Frye C.A. (2006). An overview of oral contraceptives: Mechanism of action and clinical use. Neurology, 66, S29–S36.

Hatcher R.A. Namnoum A.B. (2004). The menstrual cycle. Contraceptive Technology, 18, 63–72.

Jones B.C. Perrett D.I. Little A.C. Boothroyd L. Cornwell R.E. Feinberg D.R. . (2005). Menstrual cycle, pregnancy and oral contraceptive use alter attraction to apparent health in faces. Proceedings of the Royal Society B: Biological Sciences, 272, 347–354.

Kuukasjarvi S. Eriksson C.J.P. Koskela E. Mappes T. Nissinen K. Rantala M.J. (2004). Attractiveness of women’s body odors over the menstrual cycle: The role of oral contraceptives and receiver sex. Behavioral Ecology, 15, 579–584.

Little A.C. Jones B.C. Penton-Voak I.S. Burt D.M. Perrett D.I. (2002). Partnership status and the temporal context of relationships influence human female preferences for sexual dimorphism in male face shape. Proceedings of the Royal Society B: Biological Sciences, 269, 1095–1100.

Miller G. Tybur J.M. Jordan B.D. (2007). Ovulatory cycle effects on tip earnings by lap dancers: Economic evidence for human estrus? Evolution and Human Behavior, 28, 375–381.

Panzer C. Wise S. Fantini G. Kang D. Munarriz R. Guay A. . (2006). Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: A retrospective study in women with sexual dysfunction. Journal of Sexual Medicine, 3, 104–113.

Puts D.A. (2006). Cyclic variation in women’s preferences for masculine traits: Potential hormonal causes. Human Nature, 17, 114–127.

Roberts S.C. Gosling L.M. Carter V. Petrie M. (2008). MHC-correlated odour preferences in humans and the use of oral contraceptives. Proceedings of the Royal Society B: Biological Sciences, 275, 2715–2722.

Sprengelmeyer R. Perrett D.I. Fagan E.C. Cornwell R.E. Lobmaier J.S. Sprengelmeyer A. . (2009). The cutest little baby face: A hormonal link to sensitivity to cuteness in infant faces. Psychological Science, 20, 149–154.

Thorneycroft I.H. Stone S.C. (1972). Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroids. Contraception, 5, 129–146.

Van Heusden A.M. Fauser B. (2002). Residual ovarian activity during oral steroid contraception. Human Reproduction Update, 8, 345–358.

Wedekind C. Seebeck T. Bettens F. Paepke A.J. (1995). MHC-dependent mate preferences in humans. Proceedings of the Royal Society B: Biological Sciences, 260, 245–249.